MTNR1B and Circadian Sexual Function: What Your Genes Reveal

Last reviewed: May 12, 2026 Last updated: May 12, 2026

Written by: Jay Hastings , CEO of PlexusDx

Jay Hastings is the CEO of PlexusDx, a precision health company focused on genetic testing, blood biomarker insights, and personalized wellness recommendations. He has more than 20 years of experience across healthcare innovation, genomics, laboratory operations, healthcare investing, and strategic finance. His work has included scaling healthcare startups, leading CLIA lab integrations, and helping expand consumer access to precision health tools.

Medically reviewed by: Jayden Lee, PharmD, EMBA

Jayden Lee, PharmD, EMBA, is the PlexusDx Medical Science Liaison with a PharmD and MBA specializing in pharmacogenomics and clinical product development, with a proven ability to bridge the gap between genomic research and practical patient outcomes. Dr. Lee has more than 10 years of professional experience in clinical pharmacy, academia, and research.

This article is part of the PlexusDx Education Hub — your resource for evidence-based guidance on hormones and fertility. Browse all Hormones & Fertility education

Sexual function is not the same at midnight as it is at noon — and that difference is not merely circumstantial. It is biological, regulated by the same circadian timing system that governs sleep, metabolism, immune function, and hormone secretion. The molecular bridge between the circadian clock and sexual health runs through melatonin and its primary receptor, MT2, encoded by the gene MTNR1B. Variants in MTNR1B shape how sensitively your circadian system reads the melatonin signal that coordinates testosterone rhythmicity, autonomic tone, and the temporal window in which sexual response capacity is highest. The PlexusDx Precision Peptide Genetic Test analyzes MTNR1B as part of 14 pathways, 49 peptides, and 150+ genetic insights, placing the circadian dimension of sexual health within the complete 6-insight Sexual Health pathway alongside eNOS, DRD2, OXTR, PDE5, and melanocortin genetics.

The Circadian System and Sexual Function: Why Timing Is Biological

The circadian system is a transcription-translation feedback loop anchored in the suprachiasmatic nucleus (SCN) of the hypothalamus, with peripheral clocks in virtually every organ and tissue type. This system drives 24-hour rhythms in physiology that include hormone secretion, autonomic nervous system balance, vascular tone, and cellular metabolism. Several of its outputs are directly relevant to sexual health:

Testosterone circadian rhythm. Testosterone follows a pronounced diurnal rhythm in men — peaking in the early morning hours (approximately 6–10 AM) and reaching its nadir in the evening. This rhythm is driven by the circadian regulation of LH pulsatility from the pituitary, which in turn reflects hypothalamic GnRH timing under circadian control. The magnitude of this daily testosterone swing can be 25–50% of the morning peak value — a clinically meaningful difference in androgenic drive and sexual arousal potential at different times of day.

Autonomic nervous system circadian balance. Parasympathetic dominance — associated with vasodilation, genital engorgement, and sexual arousal capacity — is highest in the latter part of the sleep phase and early morning. Sympathetic dominance — associated with vasoconstriction, arousal suppression, and detumescence — increases through the day and peaks in the evening. The autonomic balance that governs vascular sexual response is therefore on a circadian schedule that parallels the testosterone rhythm.

Nocturnal penile tumescence (NPT). Erections during REM sleep — which occur approximately every 90 minutes through the night — are a direct output of the circadian-coupled autonomic system, not of conscious sexual stimulation. NPT is used clinically to distinguish vascular from psychogenic erectile dysfunction because it tests vascular response capacity during the circadian phase of maximum parasympathetic drive. Its presence and quality reflect both vascular health (eNOS/NOS3 genetics) and the circadian regulation that drives it.

Melatonin and reproductive axis timing. Melatonin — secreted by the pineal gland in darkness, suppressed by light — is the primary hormonal signal encoding the time-of-day and time-of-year information that synchronizes peripheral circadian clocks to the light-dark cycle. In addition to its circadian timing role, melatonin has direct effects on GnRH pulsatility, LH secretion, and testicular function through MT1 and MT2 receptors expressed in the hypothalamus, pituitary, and gonads. MTNR1B — encoding the high-affinity MT2 receptor — is the genetic variable that shapes how sensitively the reproductive axis reads this melatonin signal.

The MTNR1B Gene: What It Is and Why It Matters

MTNR1B encodes melatonin receptor 1B (MT2), a G-protein-coupled receptor (GPCR) expressed in the retina, brain (particularly the SCN, hypothalamus, and hippocampus), pituitary, gonads, and numerous peripheral tissues. MT2 has higher affinity for melatonin than the MT1 receptor and is the primary receptor through which melatonin modulates circadian phase-shifting and reproductive axis timing.

MT2 signaling — activated by the nightly melatonin rise — inhibits adenylyl cyclase (reducing cAMP), activates phospholipase C (generating IP3 and DAG), and modulates potassium and calcium channel conductances. In the SCN, MT2 activation phase-advances the circadian clock in response to early-night melatonin — the molecular mechanism through which morning light exposure and exogenous melatonin shift circadian timing. In the hypothalamus and pituitary, MT2 activation modulates GnRH and LH pulsatility, creating the seasonal and circadian regulation of testosterone secretion that evolved in photosensitive species and retains functional echoes in humans.

MTNR1B is also the gene most strongly associated with circadian glucose regulation — a metabolic connection that reflects MT2's broad role in peripheral circadian synchronization. MTNR1B variants have among the largest documented effect sizes of any common SNP for fasting glucose variation — not because melatonin directly regulates glycemia, but because MTNR1B shapes the circadian timing of insulin secretion. This metabolic connection is relevant to sexual health because insulin resistance and metabolic syndrome are among the most significant modifiable risk factors for erectile dysfunction — partially through ADMA elevation, BH4 depletion, and endothelial NOS uncoupling that directly impair eNOS function.

Key MTNR1B Variants: The Ile49Thr and Related Polymorphisms

MTNR1B carries several variants with documented functional consequences, with the most studied being:

Ile49Thr (rs10830963, G allele) — the most extensively characterized MTNR1B variant for both circadian metabolic and reproductive effects. The G allele at rs10830963 produces a threonine substitution at position 49 and is associated with higher MTNR1B expression in pancreatic beta cells and elevated fasting glucose in genome-wide association studies across multiple populations. In terms of circadian function, the G allele appears to enhance melatonin signaling — producing a stronger MT2 response to the nightly melatonin pulse. This enhanced signaling has downstream consequences for circadian clock entrainment speed, reproductive axis timing, and the metabolic effects described above. The G allele frequency is approximately 30% in European-ancestry populations, making it a common variant with population-level circadian and metabolic relevance.

His315Gln (rs4753426) — a coding variant that alters the MT2 receptor's signaling characteristics, with some evidence for differential coupling to downstream intracellular pathways. Less extensively studied than Ile49Thr for reproductive-axis-specific effects, but potentially relevant to the aggregate MTNR1B haplotype picture.

Promoter and intronic variants affecting MTNR1B expression levels in specific tissue types — particularly in retina and SCN, where MT2 density shapes the precision of circadian light-dark signal transduction. Individuals with reduced MTNR1B expression in SCN tissue have a less precisely entrained circadian clock — showing more day-to-day variability in melatonin timing and greater susceptibility to circadian disruption from light exposure and schedule irregularity.

The functional consequence of MTNR1B variants — whether through altered receptor expression, ligand sensitivity, or downstream signaling — is a change in how tightly the reproductive axis, autonomic nervous system, and peripheral sexual function are coordinated to the 24-hour light-dark cycle. Individuals with variants that produce either enhanced or reduced MT2 signaling may experience desynchronization between the circadian phase of peak sexual function and the circadian phase of peak arousal readiness — a temporal mismatch that blood testosterone measurements cannot detect.

MTNR1B and Testosterone: The Circadian Hormone Connection

The relationship between MTNR1B genetics and testosterone operates through the circadian regulation of the hypothalamic-pituitary-gonadal (HPG) axis. The nightly melatonin signal — received by MT2 receptors in the hypothalamus and pituitary — contributes to the circadian gating of GnRH pulsatility that drives the testosterone rhythm. When MTNR1B variants alter MT2 signaling characteristics, the precision and amplitude of this circadian testosterone regulation is affected:

MTNR1B variants affecting circadian entrainment speed change how quickly the testosterone rhythm adapts to schedule disruptions — shift work, travel across time zones, irregular sleep. Individuals with variants producing slower re-entrainment may show more prolonged testosterone desynchrony after schedule disruption, with the testosterone peak displaced from its usual early-morning timing and the hormonal environment for sexual arousal misaligned with wakeful activity hours.

MTNR1B variants affecting MT2 expression in gonadal tissue change the direct melatonin-to-testis signaling that modulates Leydig cell testosterone production outside of HPG axis control. MT2 receptors in testicular tissue respond to melatonin directly — and MTNR1B variants that alter testicular MT2 expression modify this direct regulatory input to testosterone production alongside the HPG axis pathway.

The clinical picture is not binary — MTNR1B variants don't simply "raise" or "lower" testosterone. They change the temporal precision of the testosterone rhythm, the amplitude of the morning peak relative to the evening nadir, and the resilience of that rhythm to circadian disruption. A man whose testosterone chronotype is disrupted by MTNR1B-related circadian asynchrony may have normal aggregate testosterone production that bloodwork captures but impaired morning testosterone availability during the circadian window when sexual arousal capacity is highest.

Light Exposure, Melatonin Suppression, and MTNR1B

Artificial light at night — from screens, indoor lighting, and urban light pollution — suppresses melatonin secretion before its natural evening onset, compressing or delaying the nightly melatonin window that MT2 receptor-mediated circadian signaling depends on. The sexual health consequences of chronic melatonin suppression through light exposure include:

Attenuated testosterone rhythm amplitude. When the melatonin signal is compressed by evening light exposure, the circadian entrainment of the HPG axis weakens — reducing the morning testosterone peak relative to the evening nadir. The testosterone rhythm becomes flatter, with less diurnal variation and a lower morning peak. For men whose sexual arousal capacity is substantially determined by morning testosterone availability, this chronobiological flattening directly reduces the hormonal foundation of their peak sexual response window.

Delayed circadian phase. Evening light exposure delays melatonin onset — pushing the circadian clock later. When sleep is constrained by work schedules, the testosterone morning peak occurs during sleep rather than during waking activity hours, reducing access to peak androgenic drive during the times when sexual activity is feasible. This is the "social jetlag" phenomenon — a misalignment between the circadian clock and the social schedule — that affects a substantial fraction of the working population and has documented associations with sexual dysfunction.

MTNR1B genotype moderates how much these light exposure effects disrupt circadian-reproductive coordination. Variants producing enhanced MT2 sensitivity may amplify the disruptive effect of melatonin suppression — because a receptor system that is highly sensitive to the melatonin signal is also more disrupted when that signal is attenuated by light. Variants producing reduced MT2 sensitivity may be more robust to melatonin suppression but also less responsive to the entraining melatonin signal under normal conditions.

MTNR1B, Sleep Quality, and the Sexual Health Cascade

Sleep disruption is among the most consistently documented and most underappreciated contributors to sexual dysfunction. The mechanisms are multiple and bidirectional:

Direct testosterone pathway. REM sleep is the primary phase of nocturnal testosterone pulsatility. Sleep fragmentation — reducing total REM time — reduces the nocturnal testosterone pulses that produce the morning peak. Studies of healthy young men with one week of sleep restriction to 5 hours per night show morning testosterone reductions of 10–15% — equivalent to a decade of age-related testosterone decline, occurring within days of sleep restriction.

Cortisol and sympathetic activation. Sleep deprivation elevates cortisol and increases sympathetic nervous system tone — both of which suppress GnRH pulsatility and increase α-adrenergic vasoconstriction that opposes the NO-mediated vasodilation sexual arousal requires. The eNOS-dependent vascular sexual response is directly impaired by the sympathetic activation that chronic sleep disruption produces.

Dopamine and reward motivation. Sleep deprivation reduces dopaminergic reward responsiveness — attenuating the motivational drive toward sexual activity that DRD2 receptor signaling mediates. The interaction between MTNR1B-related sleep quality and DRD2 dopamine signaling creates a compounded chronobiological-motivational picture that affects both the desire and the vascular capacity dimensions of sexual function simultaneously.

MTNR1B variants that impair circadian precision and sleep architecture quality amplify all three of these mechanisms — creating a sexual health impact that compounds across the testosterone, vascular, and motivational pathways simultaneously.

MTNR1B in the Full Sexual Health Genetic Panel

MTNR1B is one of 6 Sexual Health insights the Precision Peptide Genetic Test analyzes as a connected system. Its specific relationships within the panel:

eNOS/NOS3 — the vascular output that circadian autonomic tone modulates. The NO-cGMP vascular cascade that eNOS drives is directly shaped by the autonomic balance that circadian rhythmicity regulates. MTNR1B-related circadian disruption elevates sympathetic tone — directly opposing the parasympathetic, NO-facilitated vasodilation that the NOS3 → cGMP → vascular sexual response pathway depends on. Full detail: eNOS (NOS3) and Nitric Oxide Genetics.

DRD2 — dopamine reward signaling whose circadian rhythm MTNR1B governs. Dopamine receptor D2 signaling operates on a circadian schedule — with peak mesolimbic dopaminergic responsiveness during the circadian active phase. MTNR1B-related circadian disruption shifts the timing of peak DRD2 responsiveness relative to the social schedule, potentially misaligning the window of peak sexual motivation with available sexual activity time. Full detail: DRD2 Dopamine Receptor and Desire Pathways.

OXTR — oxytocin receptor signaling that peaks in circadian morning windows. Oxytocin release and OXTR-mediated bonding and arousal facilitation follow circadian rhythms that peak in temporal proximity to the testosterone and autonomic morning windows. Circadian disruption via MTNR1B-related asynchrony can decouple these overlapping windows. Full detail: OXTR Oxytocin Receptor Genetics.

Melanocortin pathway — central arousal whose output is tonically modulated by circadian state. Melanocortin receptor activation in the hypothalamus drives central sexual arousal, but the effectiveness of that activation is substantially influenced by the circadian state of the hypothalamic circuits that receive it. Circadian disruption reduces hypothalamic responsiveness to arousal-promoting inputs across multiple receptor systems. Full detail: The Melanocortin Pathway: Genetics of Central Sexual Response.

The complete framework connecting all 6 Sexual Health insights is in the Complete Guide to Genetic Sexual Health Testing.

What Your MTNR1B Results Can and Cannot Tell You

MTNR1B variant analysis reveals your genetic baseline for MT2 receptor signaling — the structural tendency of your circadian melatonin receptor system to coordinate reproductive axis timing, autonomic balance, and the chronobiological foundations of sexual function. Results do not measure your current melatonin levels, testosterone rhythm amplitude, or sleep architecture; those require specialized testing. They do not diagnose any clinical condition. And they do not predict your specific response to any circadian support approach or peptide protocol.

What they deliver is the chronobiological context that testosterone blood levels and vascular genetics cannot provide: whether your circadian regulation of sexual function is operating with high precision or with genetic tendencies toward disruption — and therefore which aspects of sleep hygiene, light management, and circadian timing optimization are most relevant to your sexual health foundation. Genetics as a guide, not a guarantee — and as one of 6 Sexual Health insights within 14 total pathways and 150+ genetic insights, MTNR1B completes the temporal dimension of the sexual health genetic picture that every other pathway insight operates within.

The Precision Peptide Genetic Test analyzes how your genes influence sexual health and related biological pathways. It does not recommend, prescribe, or determine which peptides you should use. Consult a qualified healthcare provider before beginning any peptide protocol.

Ready to understand your MTNR1B genotype and how circadian genetics shapes your sexual health profile? Take the Precision Peptide Genetic Test

Frequently Asked Questions About MTNR1B and Circadian Sexual Function

What does MTNR1B genetics reveal about sexual function?

MTNR1B variants shape MT2 receptor sensitivity to the nightly melatonin signal that synchronizes testosterone rhythmicity and the circadian timing of vascular sexual response. The Precision Peptide Genetic Test analyzes MTNR1B as part of 6 Sexual Health insights within 14 pathways, 150+ genetic insights — the chronobiological dimension no testosterone blood test captures.

How does circadian disruption affect testosterone and sexual response?

Sleep restriction reduces nocturnal testosterone pulses, flattening the morning peak. Circadian misalignment elevates cortisol and sympathetic tone — directly suppressing GnRH pulsatility and opposing the NO-mediated vascular vasodilation sexual arousal requires. MTNR1B variants modulate susceptibility to these disruptions. The Precision Peptide Genetic Test maps MTNR1B alongside eNOS and DRD2 within 6 Sexual Health insights.

Can light exposure and sleep hygiene affect MTNR1B-related sexual function?

Yes — evening light suppresses melatonin, compresses the MT2 receptor window that synchronizes testosterone timing and autonomic balance, and amplifies circadian disruption in MTNR1B variant carriers. Consistent sleep timing and reduced evening light support circadian precision. The Precision Peptide Genetic Test identifies MTNR1B genotype as part of 14 pathways and 150+ genetic insights.

This article is part of the PlexusDx Education Hub. Browse all Hormones & Fertility education

Medical and Editorial Standards

Medical review process: This article was reviewed for medical accuracy, scientific clarity, evidence alignment, and appropriate discussion of genetics, medications, supplements, biomarkers, and health-related claims.

Sources and evidence: PlexusDx educational content is developed using peer-reviewed research, clinical literature, reputable medical references, and, where applicable, public health or regulatory guidance. References are included at the end of the article when scientific, medical, or health-related claims are discussed.

Commercial transparency: PlexusDx offers genetic testing, blood biomarker testing, personalized supplement recommendations, and related precision wellness services. Product mentions are intended to help readers understand available options and should not be interpreted as medical advice.

Important disclaimer: PlexusDx educational content is for informational purposes only and should not be used as a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making decisions about medications, supplements, genetic testing, lab testing, or health-related care.